Board of Directors:
Leadership & Experience
The Board for Stemina Biomarker Discovery advises the NeuroPointDX division and includes industry leaders with the business acumen and good judgment to lead us forward.
CEO – Phoenix Technology Group
Heiner Dreismann, Ph.D.
Former President & CEO – Roche Molecular Systems; Global Head of Business Development – Roche Diagnostics
Elizabeth LR Donley, JD MBA MS
Chief Executive Officer
Chairman – Boston HealthCare
Kevin Krenitsky, MD
Former COO, CCO – Foundation Medicine
Andrew Morgan, R.Ph.
Executive Vice President, Regulatory Affairs & Quality Operations – Zurex Pharma
SVP & Chief Financial Officer, Madrigal Pharmaceuticals